Mould, Daniel P <br/><br/>
Reversible inhibitors of LSD1 as therapeutic agents in acute myeloid leukemia: clinical significance and progress to date.  [electronic resource] 

 -  Medicinal research reviews  May 2015 
 - 586-618 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1098-1128 
<br/><br/><label>Standard No.: </label>10.1002/med.21334  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--chemistry<br/>Drug Design<br/>Drug Screening Assays, Antitumor<br/>Epigenesis, Genetic<br/>Gene Expression Regulation, Leukemic<br/>Histone Demethylases--chemistry<br/>Humans<br/>Inhibitory Concentration 50<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Lysine--chemistry<br/>Mice<br/>Polyamines--chemistry<br/>Treatment Outcome